PKP2 and arrhythmogenic right ventricular cardiomyopathy: Wu, Zeng et al. assess the feasibility and efficacy of AAV9:PKP2 gene therapy in the Pkp2-cKO mouse model of arrhythmogenic right ventricular cardiomyopathy.